Grant round · GrantConnect grant opportunity
Grant round GO5590
Awards in this round describe their activity in more than one way. The most common:
- “Breaking drug resistance in community-acquired bacterial pneumonia (CABP)” (1 award)
- “Developing a new type of drug for inflammatory lung disease” (1 award)
- “Development of a New Class of Formyl Peptide Receptor 1 (FPR1) Biased Agonists for the Treatment of Myocardial Infarction” (1 award)
- “Development of a Plasmodium vivax multi-analyte lateral flow assay to accelerate malaria elimination” (1 award)
- “Development of a novel optical stimulation therapy for Obstructive Sleep Apnoea” (1 award)
$16m
whole-of-term value of 16 awards to 9 named recipients, published 2022-12-19 to 2023-01-23
$1.0m falls in 2026-27, from 5 active awards. estimate: annualised
A grant round is a grant opportunity on GrantConnect: an open or targeted call for applications under published guidelines. GrantConnect’s award lists give the opportunity’s ID but not its title; search GrantConnect for GO5590 to read its guidelines.
By agency
| Granting agency | Awards | Total value |
|---|---|---|
| National Health and Medical Research Council (NHMRC) | 16 | $16m |
Recipients, largest first
Recipients who are individuals, and awards that name no single recipient, are counted above but not listed, here or in the CSV. Why The bulk download has every award, with individuals flagged.
| Recipient | Awards | Total value |
|---|---|---|
| Monash University | 5 | $4.6m |
| University of New South Wales | 2 | $2.5m |
| The University of Queensland | 2 | $2.0m |
| University of Melbourne | 2 | $1.7m |
| The Bionics Institute of Australia | 1 | $1.3m |
| The Walter and Eliza Hall Institute of Medical Research | 1 | $1.0m |
| Adelaide University | 1 | $961k |
| The Garvan Institute of Medical Research | 1 | $867k |
| University of South Australia | 1 | $865k |